Syntiron
MN - St. PaulBiotechnology
Focus: Syntiron is a microbial vaccine biotech focused on infectious disease vaccines, headquartered in St. Paul, Minnesota. The company operates as a pre-revenue or early-stage biotech with minimal public pipeline visibility.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
7-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Syntiron?
AI assessmentSyntiron is a high-risk, early-stage vaccine biotech best suited for entrepreneurs and scientists comfortable with pre-revenue execution risk in exchange for meaningful platform-building opportunity.
Why Work Here
- Early-stage vaccine platform focused on high-impact infectious disease space with significant unmet medical need
- Cross-functional hiring across R&D, regulatory, manufacturing, and QA suggests active program advancement
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Syntiron
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.